The Acumen Team
Our mission is to turn the world’s most important ideas into enduring companies that improve lives.
/
Founder and Managing Partner
Experience spanning over 35 years working across healthcare policy, law, technology, and entrepreneurship.
Email:
doug@acumen.partners
Doug McCormack brings over 35 years of experience across healthcare policy, law, technology, and entrepreneurship.
He has founded and led three venture-backed companies spanning orthopedic medical devices, digital health, and medical robotics. He was named Fierce 15 CEO in Medical Devices by Fierce Healthcare.
Earlier in his career, Doug spent 15 years in law, policy, and advocacy. He co-founded and led the federal policy and advocacy practice at Dentons as a partner, and previously advised healthcare clients on regulatory and policy matters at ArentFox Schiff.
Doug is the founder of Acumen Partners, an investment and advisory firm focused on corporate development and M&A, early-stage healthcare ventures, providers, and medtech companies, helping them navigate complex strategic decisions.
He currently serves as Chairman of MedMatrix Rx, a management services organization focused on developing specialty provider networks for safety-net providers. He is also Co-Founder and Chairman of Biocerta Precision Therapeutics, a biotech company applying drug-sensitivity testing to improve oncology treatment selection.
Doug holds a JD from American University Washington College of Law and a bachelor’s degree from the University of Southern California. He has completed advanced coursework in AI corporate strategy at Massachusetts Institute of Technology’s Sloan School of Management, and additionally studied Health AI at Johns Hopkins Whiting School of Engineering.
He is admitted to practice law in Maryland and the District of Columbia.